Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.37 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14915157 | 0.94 | LMNA (0.39) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL16583998 | 0.93 | LMNA (0.41) | BBOX1KDM4ELMNAAPOBEC3AAPOBEC3G | |
| SCHEMBL419422 | 0.86 | — | — | |
| SCHEMBL923192 | 0.86 | — | — | |
| SCHEMBL2908299 | 0.83 | — | — | |
| SCHEMBL4798792 | 0.83 | — | — | |
| SCHEMBL1886006 | 0.81 | — | — | |
| SCHEMBL16767003 | 0.81 | — | — | |
| SCHEMBL15053253 | 0.79 | — | — | |
| SCHEMBL29112748 | 0.78 | LCK (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2766303-B1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RES & ENG CO (US) | 2017-11-22 | — | — | EP | disclosed |
| US-9035058-B2 | Synthesis of MSE-framework type molecular sieves | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-05-19 | — | — | US | disclosed |
| US-20150087841-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-03-26 | — | — | US | disclosed |
| US-8916130-B2 | Synthesis of MSE-framework type molecular sieves | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2014-12-23 | — | — | US | disclosed |
| US-20130115163-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087841-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | MRPS2, B2M, UFM1 | BBOX1 3183/4885KDM4E 486/4885LMNA 3785/4885 |
| US-20130115163-A1 | SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES | MRPS2, UFM1, B2M | BBOX1 3456/4885KDM4E 453/4885LMNA 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.